For ovarian carcinoma, presence of the BRAF V600E mutation as the marker was detected from archival paraffin-embedded ovarian tissue collected at the time of diagnosis using next generation sequencing (NGS) as a standard method for sequencing of DNA or RNA, while excluding other mutations, including BRCA 1/2 (Fig. 3). The gene discussed is BRAF; the disease is ovarian carcinoma.